Marker Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Houston, TX
MRKR chart
What traders are saying about $MRKR
Latest postsMarker Therapeutics, Inc. news
- Marker Therapeutics, Inc. Estimates – NASDAQ:MRKR
TradingView ·
- Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
Yahoo Finance ·
- All You Need to Know About MARKER THERAPEUTICS (MRKR) Rating Upgrade to Strong Buy
Yahoo Finance ·
- New Strong Buy Stocks for October 16th
Yahoo Finance ·
- Marker Therapeutics Highlights Expanded Manufacturing Support of CDMO Partner Following Formation of Kincellis Advanced Therapies
Yahoo Finance ·
- Aurinia Pharmaceuticals (AUPH) Surpasses Q2 Earnings Estimates
Yahoo Finance ·
- Zacks Industry Outlook Indivior, Aurinia, Ironwood, Altimmune and Marker
Yahoo Finance ·
- Exploring 3 High Growth Tech Stocks in US Market
Yahoo Finance ·
- Exploring High Growth Tech Stocks In The US Market
Yahoo Finance ·
- Exploring 3 High Growth Tech Stocks In The US Market
Yahoo Finance ·
- US High Growth Tech Stocks with Promising Potential
Yahoo Finance ·
- High Growth Tech Stocks To Watch In US June 2026
Yahoo Finance ·
Marker Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | – |
| Net income | -$12.2M | -$10.7M | -$8.2M | -$29.9M |
| Diluted EPS | $-0.79 | $-1.19 | $-0.94 | $-3.58 |
| Total assets (year end) | $19.1M | $22.0M | $17.1M | $34.4M |
| Cash and equivalents (year end) | $16.1M | $19.2M | $15.1M | $11.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Marker Therapeutics, Inc.
- Ticker
- MRKR (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Houston, TX
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1094038
- Former names
- TAPIMMUNE INC., TAPIMMUNE INC, GENEMAX CORP
Frequently asked questions
What exchange is Marker Therapeutics, Inc. listed on?
Marker Therapeutics, Inc. trades on the Nasdaq under the ticker symbol MRKR.
What industry is Marker Therapeutics, Inc. in?
Marker Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Marker Therapeutics, Inc. headquartered?
Marker Therapeutics, Inc.'s business address on file with the SEC is in Houston, TX.
When does Marker Therapeutics, Inc.'s fiscal year end?
Marker Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Marker Therapeutics, Inc. report?
Marker Therapeutics, Inc. reported $0 in revenue for calendar year 2021, according to its SEC filings.